Juvenile Arthritis News

Incidence of bloodstream infections in patients with juvenile idiopathic arthritis were rare, but occurred three times more often than in the general population, according to study findings.

Despite observed mild subclinical diastolic involvement, long-term anti-tumor necrosis factor cardiovascular safety was demonstrated in patients with juvenile idiopathic arthritis, according to study results.

Patients with juvenile idiopathic arthritis who undergo total elbow arthroplasty have high complication and revision rates but experience long-term benefits from intervention, according to study results.

The interleukin-6 receptor inhibitor tocilizumab reduced disease flares during and after administration compared with methotrexate or placebo among children with polyarticular juvenile idiopathic arthritis, according to a recent study.

Patients with juvenile idiopathic arthritis were more likely to achieve inactive arthritis status with one steroid joint injection, compared with those with repeated joint injections, according to data from a recent study.

Patients with juvenile idiopathic arthritis experienced altered arterial wall indices, indicating increased arterial stiffness, according to study results.

Juvenile idiopathic arthritis patients experienced decreased bone strength and multiple bone alterations over time while receiving various therapies, according to data from a recent study.

Antares Pharma has announced that LEO Pharma has launched Antares’ subcutaneous methotrexate product Otrexup to dermatologists for their adult patients with severe psoriasis.

Patients with polyarticular juvenile idiopathic arthritis had distinctly different synovial proteins compared with oligoarticular patients during an early stage of the disease, according to recent study results.

Many smaller, nonrural regions of the United States have no or few practicing rheumatologists, limiting access for patients with chronic rheumatic conditions, according to recent study results.